SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

NASAs CLPS 2.0 program is the main focus, with traders discussing Intuitive Machines selection as a vendor eligible to compete for future lunar-delivery missions. Bulls see potential contract and backlog upside, while others caution that eligibility is not a guaranteed award and note that peer companies may have fared better; the sharp rebound has also prompted speculation about momentum and short covering.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientifics Q3 results highlighted its shift from bitcoin mining toward AI and high-performance-computing colocation, with traders pointing to strong growth in that business and new capacity coming online. The reaction is divided: some see the results as proof the pivot is working, while others remain concerned about debt, financing needs, and reliance on major tenants.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyfts quarterly results missed revenue and earnings expectations, with legal, tax and regulatory reserves weighing on reported revenue and prompting a selloff. Traders are debating the weak headline results against stronger bookings, rider growth, adjusted profitability and constructive guidance.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Runs AI-cloud contract update, including a five-year GPU compute agreement and delivery progress on an earlier project, is drawing attention. Bulls view the developments as evidence of customer demand, while skeptics point to the stocks sharp decline, profitability and financing risks, and the need for earnings to show contracts converting into revenue.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys rally is centered on a large AST SpaceMobile agreement for rocket engines, engine-technology licensing, and engineering support, which traders view as validation of its propulsion business and a boost to its backlog. The reaction is broadly bullish, though some investors question the deals stock component and execution risks as the shares surge.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Falling lithium prices and futures are the main concern, with traders linking them to ALBs weakness and questioning whether the shares near $100 have found a floor. Some see the pullback as a buying opportunity based on long-term battery demand, while others expect further downside and are watching earnings and guidance for signs of a turnaround.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Amazons planned acquisition of Globalstar dominates discussion, with traders focusing on the cash-and-stock deal terms, its expected closing, and why GSAT trades below the stated consideration. Some hope for a superior SpaceX bid, but others view that as speculation and expect the Amazon transaction to proceed, subject to remaining conditions.

Polkadot (DOT) is a cryptocurrency . Polkadot has a current supply of 1,710,919,378.06579952. The last known price of Polkadot is 0.90890211 USD and is down -1.57 over the last 24 hours. It is currently trading on 1075 active market(s) with $54,388,530.28 traded over the last 24 hours. More information can be found at https://polkadot.com.

Polkadot

DOT is drawing attention after its prolonged decline and move below a key psychological level, with bearish traders citing weak demand and continued losses. Others are buying the dip and pointing to Polkadot 2.0, JAM, and a proposed native stablecoin as potential catalysts, though those bullish views have not displaced the dominant concern about the downtrend.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is under pressure as traders question whether AI data-center fiber demand will arrive quickly enough to justify expectations, warning that delayed or unfilled facilities could leave fiber orders ahead of real usage. Others see the pullback as a buying opportunity, arguing that ongoing AI and telecom network buildouts support long-term demand.

Official Melania Meme (MELANIA) is a cryptocurrency and operates on the Solana platform. Official Melania Meme has a current supply of 999,995,428.757519 with 999,995,428.757515 in circulation. The last known price of Official Melania Meme is 0.06224781 USD and is up 1.19 over the last 24 hours. It is currently trading on 310 active market(s) with $4,914,204.93 traded over the last 24 hours. More information can be found at https://melaniameme.com/.

Melania Trump

MELANIA is drawing attention as traders criticize its steep decline and lack of apparent utility, with many calling it a failed cash grab and warning that holders may be left with losses. Discussion of Trump family crypto profits has intensified those concerns, though a smaller group is still speculating on a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock?

Agilent Technologies gears up for Q4 fiscal 2026 earnings, with revenues and EPS growth expected amid strength in chromatography, spectroscopy and consumables.

Aardvark Therapeutics Stock Surges as FDA Lifts Clinical Hold After Cardiac Safety Concerns

Aardvark Therapeutics shares jumped 25.06% after hours as the FDA lifted its clinical hold on ARD-101 development.read more...

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 41.9% to $0.46 during Thursday's after-market session. The company's market cap stands at $67.1 million.
Aardvark Therapeutics (NASDAQ:AARD) stockread more...

All You Need to Know About Aardvark Therapeutics, Inc. (AARD) Rating Upgrade to Buy

Aardvark Therapeutics, Inc. (AARD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aardvark Therapeutics, Inc. (Aardvark or the Company) (NASDAQ: AARD) and reminds investors of the October 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action...

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud LawsuitPR NewswireNEW YORK, Oct. 12, 2026NEW YORK, Oct. 12, 2026 /PRNewswire/ --Why: Rosen...

AARD FINAL DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

AARD FINAL DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit AARD FINAL DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action LawsuitPR NewswireSAN...

Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD

Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARDPR NewswireNEW YORK, Oct. 12, 2026NEW YORK, Oct. 12, 2026...

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS LawPR NewswireLOS ANGELES, Oct. 12, 2026LOS ANGELES, Oct. 12, 2026 /PRNewswire/ -- Schall...

Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit

Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action LawsuitPR NewswireSAN FRANCISCO, Oct. 8, 2026SAN FRANCISCO...

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

AARD Stock Crashes 34% – Here’s Why This Analyst Finds It ‘Hard To Lean Into’ Aardvark At This Stage

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>BTIG downgraded Aardvark Therapeutics to ‘Neutral’ from ‘Buy’ but did not provide a price target, according to The Fly.</li><li>The firm said it is hard to bet on Aardvark given the uncertainties and the lack of a clear timeline on when the issues can be resolved.</li><li>Morgan Stanley downgraded the stock and said the path forward remains unclear.</li></ul>Shares of Aardvark Therapeutics (AARD) plummeted more than 34% on Friday, to hit their lowest levels in over a month, following the U.S. Food and Drug Administration’s decision to impose a full clinical hold on the firm’s lead therapy candidate across all ongoing studies targeting hyperphagia in patients with Prader-Willi Syndrome.The clinical hold follows the company’s voluntary <a href="https://stocktwits.com/news-articles/markets/equity/aard-stock-plummets-after-hours-as-cardiac-safety-concerns-trigger-fda-hold-on-late-stage-program/cZXSEPUReSj">pause</a> of the program in late February 2026, after reversible heart-related findings were observed at very high doses in a healthy volunteer study.Following the FDA’s decision, Wall Street turned skeptical about the stock, with at least two firms downgrading the stock.<h2 class="st-heading-2">BTIG Flags Three Crucial Points For Near-Term Outlook</h2>BTIG downgraded Aardvark Therapeutics to ‘Neutral’ from ‘Buy’ but did not provide a price target, according to The Fly.The firm said the stock’s near-term outlook now depends on several key factors falling into place, including a clearer understanding of the drug’s exposure levels and cardiac safety signals, positive efficacy data from the unblinded HERO study, and the company’s ability to establish a viable regulatory path while operating within its cash runway through mid-2027.Given those uncertainties and the lack of clear timelines, the firm said it “makes it hard to lean into AARD at this juncture.”<h2 class="st-heading-2">Morgan Stanley Downgrades AARD</h2>Morgan Stanley downgraded the stock to ‘Underweight’ from ‘Equal Weight’ and cut its price target to $3 from $7, according to The Fly. The firm said that while the unblinded data “could provide insights,” it could take some time, and a path forward for the therapy remains unclear.B. Riley noted that the company plans to unblind existing trial data in the near term and remains in discussions with regulators, with a potential path forward likely centered on a lower-dose version of the treatment, despite ongoing concerns about the cardiac safety findings. Despite lowering the price target to $7 from $8, the brokerage maintained a ‘Buy’ rating.On Thursday, Aardvark had mentioned its plans to unblind the clinical data collected so far for ARD-101 to better evaluate the treatment’s safety and effectiveness and determine the next steps for the program.<h2 class="st-heading-2">How Did Retail React To AARD’s Slump?</h2>Despite the intra-day slump, retail sentiment on <a href="https://stocktwits.com/symbol/AARD">AARD</a> turned ‘bullish’ from ‘neutral’ a day earlier, while message volumes remained ‘high.’One user sees an opportunity to pick up the stock at under $3. It is currently trading at $5.<stembedurl>https://stocktwits.com/Xxxxcccemre/message/653485987</stembedurl>The stock has lost nearly 65% of its value so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/peter-schiff-calls-metals-slump-a-great-buying-opportunity-silver-suffers-steepest-single-day-drop-in-over-2-months/cZXmRm5Rejy">Peter Schiff Calls Metals Slump A ‘Great Buying Opportunity’ – Silver Suffers Steepest Single-Day Drop In Over 2 Months</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

Following a clinical hold on its lead drug candidate, multiple brokerages downgraded and cut AARD’s price target.

Aardvark Therapeutics Inc

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.17
Prev Close	$1.11
Open	$1.10
Dividend Yield	0.00%
50-Day Moving Average	$4.21
Beta	2.29
Avg. Volume	1.48M
PE Ratio	-0.37

52-Week High	$16.60
52-Week Low	$0.93
Market Capitalization	$25.61M
EPS (Annual)	-$2.64
Price to Book	0.34
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

AARD Fundamentals